Ferrous fumarate or ferrostrane

PreclinicalSmall molecule

Ferrous fumarate or ferrostrane is one of 5 small molecule programs targeting Craniosynostosis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CraniosynostosisActive, not recruiting

CraniosynostosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Craniosynostosis

#DrugCompanyPhaseTrials

Sevofluorane

TTamas Vegh, MD

Approved

1 2

Low Dose TXA

BBoston Children's Hospital

Approved

1 3

High Dose TXA

BBoston Children's Hospital

Approved

1 4

Cyklokapron

AAmring

Preclinical

1 5

Ferrous fumarate or ferrostrane

UUniversity Hospital, Montpellier

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Randomized1 trial

Cross Iron (Comparative Randomized Oral Versus Systemic IRON)

Completed·UUniversity Hospital, Montpellier·N/A·NCT02496377·100 enrolled

Craniosynostosis1 trial

Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child

Completed·UUniversity Hospital, Montpellier·N/A·NCT03231085·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Ferrous fumarate or ferrostrane. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ferrous fumarate or ferrostrane compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ferrous fumarate or ferrostrane. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Montpellier company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Montpellier

Ferrous fumarate or ferrostrane

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Randomized1 trial

Craniosynostosis1 trial

References

Drug Info

Quick Facts

Related News